Darunavir
- Strength
- 800 mg/1
- Form
- Tablet, Film Coated
- Class
- Protease Inhibitor
Viona Pharmaceuticals Inc
Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide
Listed by Janssen Products LP
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Cytochrome P450 3A Inhibitor; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Protease Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 59676-800 |
| FDA application | NDA210455 |
| RxNorm concept | 2049671 |
| Package sizes listed | 2 |
| Marketed since | July 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Viona Pharmaceuticals Inc
Camber Pharmaceuticals, Inc.
Dr.Reddys Laboratories Inc
American Health Packaging
Zydus Lifesciences Limited
Camber Pharmaceuticals, Inc.
Zydus Lifesciences Limited
Novadoz Pharmaceuticals LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.